Literature DB >> 22497728

Retinal neuropathy precedes vasculopathy in diabetes: a function-based opportunity for early treatment intervention?

Anthony J Adams1, Marcus A Bearse.   

Abstract

Diabetes, now at epidemic levels, can have devastating effects on the eye and vision. Treatments of the ocular complications are currently focused on relatively advanced stages and are limited to the slowing down of the progressive sight-threatening retinal vasculopathy (diabetic retinopathy). Tiny signals from the neural retina have been shown to reveal early diabetic neuropathy prior to vascular retinopathy. These signals, in a clinical test format, are predictive, by precise retinal location, of impending vasculopathy in the retina within a year, including sight-threatening oedema. The discovery opens possibilities for the future development of treatments to prevent the onset of retinopathy and the more sight-threatening retinal oedema and changes patient management strategies.
© 2012 The Authors. Clinical and Experimental Optometry © 2012 Optometrists Association Australia.

Entities:  

Mesh:

Year:  2012        PMID: 22497728     DOI: 10.1111/j.1444-0938.2012.00733.x

Source DB:  PubMed          Journal:  Clin Exp Optom        ISSN: 0816-4622            Impact factor:   2.742


  28 in total

Review 1.  Diabetic retinopathy is a neurodegenerative disorder.

Authors:  Stephanie K Lynch; Michael D Abràmoff
Journal:  Vision Res       Date:  2017-04-28       Impact factor: 1.886

2.  Electrophysiological measures of dysfunction in early-stage diabetic retinopathy: No correlation between cone phototransduction and oscillatory potential abnormalities.

Authors:  J Jason McAnany; Karen Liu; Jason C Park
Journal:  Doc Ophthalmol       Date:  2019-09-11       Impact factor: 2.379

3.  Electrophysiological and pupillometric measures of inner retina function in nonproliferative diabetic retinopathy.

Authors:  Jason C Park; Felix Y Chau; Jennifer I Lim; J Jason McAnany
Journal:  Doc Ophthalmol       Date:  2019-04-23       Impact factor: 2.379

4.  Temporal Frequency Abnormalities in Early-Stage Diabetic Retinopathy Assessed by Electroretinography.

Authors:  J Jason McAnany; Jason C Park
Journal:  Invest Ophthalmol Vis Sci       Date:  2018-10-01       Impact factor: 4.799

5.  Consumption of a high fat diet promotes protein O-GlcNAcylation in mouse retina via NR4A1-dependent GFAT2 expression.

Authors:  Weiwei Dai; Sadie K Dierschke; Allyson L Toro; Michael D Dennis
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2018-09-11       Impact factor: 5.187

6.  Retinal neurodegeneration may precede microvascular changes characteristic of diabetic retinopathy in diabetes mellitus.

Authors:  Elliott H Sohn; Hille W van Dijk; Chunhua Jiao; Pauline H B Kok; Woojin Jeong; Nazli Demirkaya; Allison Garmager; Ferdinand Wit; Murat Kucukevcilioglu; Mirjam E J van Velthoven; J Hans DeVries; Robert F Mullins; Markus H Kuehn; Reinier Otto Schlingemann; Milan Sonka; Frank D Verbraak; Michael David Abràmoff
Journal:  Proc Natl Acad Sci U S A       Date:  2016-04-25       Impact factor: 11.205

7.  Multifocal electroretinogram in diabetic macular edema and its correlation with different optical coherence tomography features.

Authors:  Hassan Khojasteh; Hamid Riazi-Esfahani; Elias Khalili Pour; Hooshang Faghihi; Fariba Ghassemi; Fatemeh Bazvand; Raziyeh Mahmoudzadeh; Mirataollah Salabati; Masoud Mirghorbani; Mohammad Riazi Esfahani
Journal:  Int Ophthalmol       Date:  2019-11-11       Impact factor: 2.031

Review 8.  Preventing diabetic retinopathy by mitigating subretinal space oxidative stress in vivo.

Authors:  Bruce A Berkowitz
Journal:  Vis Neurosci       Date:  2020-06-15       Impact factor: 3.241

Review 9.  MRI biomarkers for evaluation of treatment efficacy in preclinical diabetic retinopathy.

Authors:  Bruce A Berkowitz; David Bissig; Oliver Dutczak; Shannon Corbett; Rob North; Robin Roberts
Journal:  Expert Opin Med Diagn       Date:  2013-06-21

Review 10.  The stress response protein REDD1 as a causal factor for oxidative stress in diabetic retinopathy.

Authors:  William P Miller; Siddharth Sunilkumar; Michael D Dennis
Journal:  Free Radic Biol Med       Date:  2021-01-29       Impact factor: 7.376

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.